Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Oral Midazolam Plus Intranasal Dexmedetomidine for MRI Sedation in Children (Modified Dixon Up-and-Down Method)
ChiCTR2300068611Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, School of Medicine, Zhejiang University
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of dexmedetomidine and midazolam, sponsored by Children's Hospital, School of Medicine, Zhejiang University. Primary endpoints: Sleep latency, Recovery time and 1 more. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinemidazolam
Beyond the preview
Go deeper on ChiCTR2300068611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068611.